New Zealand markets close in 47 minutes

Pediatrix Medical Group, Inc. (MD)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
8.22+0.05 (+0.61%)
At close: 04:00PM EDT
8.23 +0.01 (+0.12%)
After hours: 06:40PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 691.69M
Enterprise value 1.35B
Trailing P/E N/A
Forward P/E 6.29
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.34
Price/book (mrq)0.81
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.59
52-week change 3-42.32%
S&P500 52-week change 326.27%
52-week high 315.02
52-week low 37.70
50-day moving average 39.17
200-day moving average 310.60

Share statistics

Avg vol (3-month) 3739.94k
Avg vol (10-day) 3847.25k
Shares outstanding 584.15M
Implied shares outstanding 687.55M
Float 881.69M
% held by insiders 11.37%
% held by institutions 1104.25%
Shares short (30 Apr 2024) 44.67M
Short ratio (30 Apr 2024) 47.9
Short % of float (30 Apr 2024) 47.92%
Short % of shares outstanding (30 Apr 2024) 45.56%
Shares short (prior month 28 Mar 2024) 44.12M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 22:1
Last split date 320 Dec 2013

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -3.53%
Operating margin (ttm)4.92%

Management effectiveness

Return on assets (ttm)4.24%
Return on equity (ttm)-7.99%

Income statement

Revenue (ttm)2B
Revenue per share (ttm)24.24
Quarterly revenue growth (yoy)0.80%
Gross profit (ttm)N/A
EBITDA 189.71M
Net income avi to common (ttm)-70.58M
Diluted EPS (ttm)-0.12
Quarterly earnings growth (yoy)-71.60%

Balance sheet

Total cash (mrq)115.47M
Total cash per share (mrq)1.39
Total debt (mrq)778.66M
Total debt/equity (mrq)90.94%
Current ratio (mrq)1.73
Book value per share (mrq)10.36

Cash flow statement

Operating cash flow (ttm)113.02M
Levered free cash flow (ttm)43.23M